openheart.bmj16h
Epidemiology of myocarditis following COVID-19 or influenza and use of diagnostic assessments
Background Previous research has suggested a heightened risk of acute myocarditis after COVID-19 infection. However, it is ...
openheart.bmj8d
Hyperuricaemia elevates risk of short-term readmission and mortality in patients with heart failure
Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Serum uric acid (SUA), a product of ...
openheart.bmj11d
Predicting troponin biomarker elevation from electrocardiograms using a deep neural network
Background Elevated troponin levels are a sensitive biomarker for cardiac injury. The quick and reliable prediction of ...
openheart.bmj11d
Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoea
Background Obstructive sleep apnoea (OSA) can cause left atrial (LA) and left ventricular (LV) remodelling, which is linked ...
openheart.bmj14d
Prognostic value of multimodality imaging in the contemporary management of cardiac sarcoidosis
Background Echocardiography, cardiac magnetic resonance and cardiac 18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging play key roles in the diagnosis and management of cardiac ...
openheart.bmj6d
Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study
2 ANZAC Medical Research Institute, Sydney, New South Wales, Australia Objectives Patients with schizophrenia treated with clozapine are at risk of acute myocarditis and dilated cardiomyopathy.
openheart.bmj8d
Daylight savings time and myocardial infarction
Background Prior research has shown a transient increase in the incidence of acute myocardial infarction (AMI) after daylight savings time (DST) in the spring as well as a decrease in AMI after ...